Beginning 1 January 2023, temporary additional indications to make medicinal products for the treatment of life-threatening diseases will be available to patients as quickly as possible, and it will be possible for temporary authorization to be granted under certain conditions defined by law (Art. 9a TPA in conjunction with Art. 18 TPLO).
Read more online